Literature DB >> 452938

Fatal reactions to drugs. A 10-year material from the Swedish Adverse Drug Reaction Committee.

L E Böttiger, A K Furhoff, L Holmberg.   

Abstract

Drug-induced deaths (n = 274) in Sweden during a 10-year period have been analyzed. The incidence has been remarkably constant, with 25--30 reported cases per year. There is a marked increase with age in the incidence of fatal reactions, more so than for all drug reactions. Women consume more drugs than men and get more reactions, but not more fatal reactions. Anti-inflammatory drugs (antibiotics and sulfonamides) are responsible for 21% of the fatal reactions, followed by oral antidiabetics (9%), oral contraceptives (9%) and antiphlogistic drugs (8%). The blood and the bone marrow are the most susceptible organs, responsible for 40% of the fatal reactions, followed by thromboembolism (10%) and hepatocellular damage (9%). It is important to note that rapid changes have occurred with regard to responsible drugs as well as to the types of adverse reactions encountered.

Entities:  

Mesh:

Year:  1979        PMID: 452938

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

Review 1.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

2.  Effect of adverse drug reactions on length of stay in intensive care units.

Authors:  E Vargas; J Simón; J C Martin; M Puerro; M A Gonzalez-Callejo; M Jaime; B Gomez-Mayoral; F Duque; A Gomez-Delgado; A Moreno
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 3.  Drug-induced hepatic disorders. Incidence, management and avoidance.

Authors:  M Døssing; J Sonne
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

4.  Drug-Related Deaths in China: An Analysis of a Spontaneous Reporting System.

Authors:  Haona Li; Jianxiong Deng; Peiming Yu; Xuequn Ren
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.